Sunday, February 19, 2012

Vivus obesity drug has safety risks: FDA staff (Reuters)

[unable to retrieve full-text content]Reuters - Vivus Inc's obesity drug Qnexa helped people lose weight but may cause long-term health problems in overweight and obese patients, U.S. drugs reviewers said.

Source: http://us.rd.yahoo.com/dailynews/rss/health/*http%3A//news.yahoo.com/s/nm/20120217/hl_nm/us_fda_vivus_qnexa

tanuki mirror mirror trailer bob knight bob knight lavar arrington hope solo dancing with the stars hope solo dancing with the stars

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.